Company Overview

Emami Limited operates as a diversified personal care and healthcare company with over 25 brands and more than 1,000 products. The company reaches over 7.1 crore consumer households through a network of more than 5.4 million retail outlets across India, with presence spanning more than 70 countries. The company sells more than 140 products every second globally.

FY26 Financial Performance

Revenue: Consolidated revenue of ₹3,779 crore (broadly stable year-on-year)

Profitability: EBITDA of ₹964 crore at 25.5% margin; Profit After Tax of ₹775 crore at 20.5% PAT margin

Returns: Return on Equity approximately 30%

Balance Sheet: Debt-equity ratio of 0.04x (virtually debt-free); Net cash surplus of ₹883 crore as of 31st March 2026

Dividend: Declared interim dividends amounting to 1000% or ₹10 per equity share, totaling ₹436.5 crore payout to shareholders

Operational Challenges in FY26

The company faced three significant headwinds during FY26:

  • Weak and unseasonal summer softened demand for talc and prickly heat powder portfolio
  • Transition to new GST regime created temporary trade disruptions
  • Escalation of West Asia conflict added volatility to commodity prices, freight costs, supply chains, and consumer sentiment

Strategic Priorities and Progress

1. Premiumising and Expanding the Core

  • Non-seasonal portfolio now contributes 56% of domestic business (up from 50% in FY20)
  • New-age and mainstream brands grew from 7% to 21% of domestic business since FY20
  • Brand extensions implemented across portfolio:
  • Zandu: Expanded pain management franchise to gels, sprays, and roll-ons beyond traditional balms
  • Kesh King: Evolved through Kesh King Gold, serums, organic solutions, shampoo, and onion range
  • BoroPlus: Transformed from winter-centric antiseptic cream to year-round franchise with aloe vera gel, lip balm, soft cream, and lotions
  • Dermicool: Expanded into soaps, shower gels, prickly heat spray, and HER segment
  • Smart And Handsome: Repositioned to widen male grooming addressable market
  • Launched Zanducare digital healthcare initiative along with cough syrup and health juices
  • R&D investment of ₹31 crore with 166 experts, leading to 58 new products and variants launched in FY26

2. Building Next-Generation Growth Engines

  • Strategic investments portfolio contributed approximately 6% of consolidated turnover in FY26
  • Expected to contribute approximately 16% in FY27 and scale to 25% by FY30
  • Recent acquisitions:
  • Majority stake in Axiom Ayurveda (AloFrut brand)
  • Majority stake in IncNut Digital (Vedix and SkinKraft brands)
  • Historical inorganic growth includes Himani (1978), Zandu, Kesh King, Creme 21, and Dermicool
  • Since 2017: Strategic stakes in The Man Company and Brillare

3. Building Digital as Core Capability

  • Digital media accounts for more than 50% of total ATL investments
  • Three transformation initiatives underway:
  • Project SETU: Strengthening supply chain planning and distributor visibility
  • SalesCode.AI: Enhancing field force productivity
  • Analytics Hub: Building enterprise-wide platform for data and AI-driven decision-making
  • All digital initiatives on track for completion within FY27

International Business Performance

  • Contributes approximately 18% of consolidated revenue
  • Spans more than 70 countries across SAARC, MENAP, CIS, and African markets
  • Grew at 8% until February 2026, but West Asia conflict disruptions led to March decline
  • Full-year growth moderated to 3% due to regional volatility
  • Response included strengthened distributor partnerships, sharpened execution across modern trade and digital channels, increased localization, and improved regional team responsiveness

Q1 FY27 Performance Update

  • Consolidated revenues grew 15% to ₹1,039 crore
  • Domestic Business grew 20% with healthy like-to-like growth of 12% on comparable basis
  • Channel transformation: Organized channels grew 19% and contributed 32% of domestic business
  • Quick commerce accounts for 35% of e-commerce sales
  • EBITDA grew 6% to ₹226 crore despite gross margin pressure from higher crude oil prices and packaging cost inflation
  • Profit Before Tax grew 4% to ₹195 crore

Human Capital and Governance

  • 5,400+ employees and workers as of 31st March 2026
  • Human capital investment of ₹479 crore in FY26
  • Employee retention rate of 88%
  • 9,100+ classroom and online training sessions reaching 84% of workforce
  • Governance structure combines promoter wisdom (Mr. R.S. Agarwal), next-generation promoter leadership, and professional Independent Directors

Sustainability Initiatives

  • Energy consumption reduced by 21% since FY22
  • Energy intensity reduced by 26% since FY22
  • Water consumption reduced by 53% since FY22
  • Water intensity improved by 56% since FY22
  • Scope 1 and Scope 2 emissions reduced by 25% since FY20
  • Emission intensity improved by 30% since FY20
  • Renewable sources account for 21% of India operations' energy requirements
  • Maintained plastic neutrality across operations
  • Recycled over 7,500 metric tonnes of plastic waste in FY26

Corporate Social Responsibility

  • Invested more than ₹15 crore across 30+ community development programmes
  • Programmes focused on healthcare, education, livelihood generation, and community welfare
  • Positively impacted nearly 8 lakh lives across India
  • Initiatives conducted through Emami Foundation covering healthcare, education, skilling, women's empowerment, community welfare, sports, and fine arts

Outlook and Growth Drivers

  • Rural demand recovery due to favorable monsoon, improving agricultural output, and rising affordability
  • GST rationalization expected to widen access to organized categories
  • Urban premiumization continuing with focus on wellness, digital adoption, and trusted brands
  • Company positioned as more diversified, digitally capable, financially stronger, and disciplined than at any point in history